Tryozi’s headline prices make the decision look straightforward: compounded semaglutide injections for $79 per month or compounded tirzepatide injections for $129 per month, both advertised as lifetime deals. The harder question is what happens between completing the intake form and receiving a renewal charge. Its marketing says there is no membership, while its policies describe a subscription membership that starts billing when intake is completed. For someone budgeting ongoing care, that difference matters as much as the advertised amount.
This documentary review examines Tryozi’s public materials consulted October 19, 2026, not a purchased treatment experience. The platform documents online evaluation, prescription coordination, pharmacy fulfillment and ongoing support, alongside brand-name options. It also publishes useful prices rather than requiring every reader to request a quote. However, the materials do not fully reconcile monthly cards with multi-week prepayment language, universal inclusions with variable benefits, or several different refund promises. The practical task is to establish which terms apply to the exact purchase before authorizing payment.
At a glance
- Compounded injection prices
- Tryozi advertises semaglutide at $79 monthly and tirzepatide at $129 monthly as lifetime deals, prepared by pharmacies it describes as licensed U.S. 503A pharmacies.Sources: [5]
- Brand-name prices
- Ozempic is advertised at $1,299 billed monthly and Zepbound at $1,399 billed monthly; availability and coverage may vary.Sources: [5]
- First payment
- The subscription policy says the first month is charged when the intake form is completed, despite advertising a free, no-obligation clinical review.
- Cancellation deadline
- Cancellation must be received at least 72 hours before billing; otherwise another cycle is charged before cancellation takes effect.Sources: [8]
Read the price cards as offers, not a complete budget
Tryozi’s compounded semaglutide card specifies an injection, $79 billed monthly, and a lifetime deal. It displays $279 as the original price and advertises a $200 saving. The compounded tirzepatide injection card lists $129 billed monthly against an original $379, with a stated $250 saving. These are the provider’s comparisons, not independently established market savings. Tryozi also advertises the same price at every dose, but the materials do not explain whether that promise survives a treatment interruption or later re-enrollment.
The brand-name cards are materially different purchases: Ozempic, described as a brand-name semaglutide option, is $1,299 billed monthly; Zepbound, described as a brand-name tirzepatide option, is $1,399 billed monthly. Both carry availability-and-coverage qualifications. The supplied cards do not establish presentation, quantity or patient-specific coverage. They therefore support reporting the advertised monthly prices, not assuming that every applicant can obtain either medicine at that amount under identical conditions.
The lifetime wording is not presented as an introductory month followed by a specified higher renewal price. Still, the conditions needed to retain it are undocumented in the supplied evidence. A countdown also deserves context: Tryozi expressly says its offer clock repeats every seven hours and 51 minutes. That recurring display does not establish a unique expiration deadline. Before treating urgency as a reason to enroll, obtain the applicable price and continuation conditions in writing.
| Advertised option | Published charge | Qualification to retain |
|---|---|---|
| Compounded semaglutide injection | $79 billed monthly; lifetime deal | 503A pharmacy preparation claimed; continuation conditions not specified |
| Compounded tirzepatide injection | $129 billed monthly; lifetime deal | Same price at every dose advertised; continuation conditions not specified |
| Ozempic, brand-name semaglutide | $1,299 billed monthly | Availability and coverage may vary; presentation not established |
| Zepbound, brand-name tirzepatide | $1,399 billed monthly | Availability and coverage may vary; presentation not established |
| Multi-week plans, where applicable | Full plan amount collected once at the start | Applicable plans and total amounts are not identified in the supplied cards |
Establish what triggers the first charge
Tryozi’s homepage describes an online health-and-goals form followed by clinician review in one to two days, advertised as free and without obligation. Its intake page offers a two-minute quiz for a personalized estimate and treatment options. Neither statement, by itself, establishes prescription approval. More importantly for cash flow, the subscription policy says membership and access begin when the intake form is completed, at which point the first month is charged. The supplied pages do not clearly distinguish the estimate quiz from the charge-triggering intake.
That leaves an unresolved sequence: when does the reader authorize payment, when does clinical review occur, and which step can be completed without a charge? Tryozi separately states that payment does not guarantee a prescription will be written or dispensed. Readers should ask for the exact checkout amount and charging event rather than assume that a free review means no payment information or collection before approval. Our guide to the first GLP-1 payment explains why these are separate questions.
A second provision says multi-week plans collect the full plan amount once, upfront, with medication shipping every four weeks afterward. It does not identify which monthly cards fall under that provision or disclose the relevant total. This is not evidence that every customer must prepay multiple months. It is an unresolved scope question. Four-week shipping also differs from calendar-month billing; neither a package duration nor a shipping interval establishes the quantity dispensed or a minimum commitment.
Check the bundle before comparing its price
Tryozi’s homepage presents an unusually broad bundle: licensed-clinician consultations, standard base laboratory testing through Quest or Labcorp, medication, discreet home shipping and round-the-clock patient support. It says the standard labs are covered for the patient and describes ongoing check-ins. Those inclusions could materially affect a comparison with a medication-only quote. They are provider representations, however, and the supplied materials do not itemize the laboratory panel or explain how frequently those tests are covered.
The subscription policy narrows the certainty of that homepage list by saying services, labs and medications covered by the single subscription price may vary. It does not explain the variation by product, plan or circumstance. Consequently, the evidence does not support a blanket assurance that every advertised price includes every listed service without exception. A useful written quote should identify the selected medicine, consultations, exact laboratory coverage, shipping and any circumstance that creates a separate charge.
Support availability also needs to be distinguished from a defined clinical service. Tryozi advertises access to a real care-team member at any time, but the supplied evidence does not specify clinician response times, consultation format or follow-up frequency. Nor does it establish that every potential care request is included without an additional fee. Use the provider’s list as a starting point for an included-costs checklist, not as a substitute for the terms of the selected plan.
Renewal and cancellation determine the exit cost
The homepage’s no-membership and no-lock-in language sits alongside terms that explicitly provide for automatically renewing subscriptions. The terms authorize charges for selected services plus applicable taxes until cancellation under the policy. These statements should be read together rather than treating the advertising as proof of a one-time purchase. The record does not establish a minimum treatment duration, but recurring billing is documented. The date of that billing matters more operationally than a general promise that cancellation is available.
Tryozi requires a cancellation request to be received at least 72 hours before the billing date. A late request means the next cycle is charged and cancellation takes effect on the subsequent billing date. Requests can go through customer service or the online-account process, if available. The policy says services continue through the end of the billing cycle after cancellation. Keeping a dated request and confirmation would help document whether the notice requirement was met; merely stopping use is not the published cancellation procedure.
Refund language is less consistent. The policy introduction promises a full refund for medical disqualification, while another clause describes refunding remaining charges after disqualification. Other language says a refund may be issued and limits approved refunds to the most recent cycle, excluding earlier cycles. Nonmedical cancellation is expressly nonrefundable. These provisions do not establish one clear reimbursement outcome for every situation. Our cancellation and refund guide helps separate ending future billing from recovering money already collected.
Identify the organizations behind each part of the purchase
The named operator is Tryozi Group LLC, with a published address at 21113 Johnson Street, Suite 101, Pembroke Pines, Florida 33029. Tryozi describes itself as a patient-management platform, not the direct provider of medical or pharmacy services. Its terms assign clinical care, prescribing and fulfillment to licensed clinicians and pharmacies through OpenLoop Health and affiliated medical groups. This division matters when seeking an explanation of a charge, a prescription decision or a dispensing problem: those responsibilities are not necessarily handled by one organization.
OpenLoop coordinates partner pharmacies, and the terms allow prescriptions to move among them for fulfillment reasons. Named partners are RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. The materials do not establish which pharmacy would serve a particular patient or identify which partner would compound a particular prescription. A dispensing relationship is not itself proof of who prepared a compounded product. The site’s licensing descriptions were not independently verified in this documentary review.
Tryozi advertises service across all 50 states and Washington, D.C., but qualifies that some services may not be available in every jurisdiction and that availability can change. Its general screening language lists BMI of at least 27, or at least 25 with a related condition, and ages 18–74 for new patients. These are Tryozi’s stated screening criteria, not a guarantee of eligibility or a general treatment recommendation. A licensed clinician makes the final decision.
Delivery and follow-up are part of the value calculation
The advertised journey places clinician review at one to two days and medication at approximately a week, conditional on approval. Its wording moves from getting medication to shipping it to the door without cleanly separating preparation, dispatch and arrival. That is not a guaranteed delivery date. The supplied evidence does not specify a carrier, transit period, tracking arrangements or cold-chain procedure. Anyone coordinating a first delivery should ask which milestone the estimate describes and whom to contact if it is missed.
For fulfillment errors, Tryozi’s policy says damaged items may be replaced by the pharmacy after evidence of damage, while incorrect medications will be replaced by the pharmacy. Those provisions do not establish compensation or replacement rules for every delay, lost parcel or temperature problem. FDA guidance supplies an important separate boundary: do not use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration; contact the provider or dispensing pharmacy to resolve the concern.
Tryozi promises ongoing check-ins and 24/7 care-team access, but not a documented schedule or guaranteed clinician response time. From a cost perspective, the unanswered question is what ongoing care the recurring charge actually purchases. NIDDK describes follow-up as involving tolerance and response, not just renewed payments. Ask how clinical reassessment is arranged, who reviews concerns and whether any additional visit or testing falls outside the selected plan before assigning a monetary value to unlimited-sounding support language.
Payment methods are not insurance coverage
Published payment methods are Visa, Mastercard, FSA/HSA, Apple Pay and Google Pay; American Express is not accepted. Tryozi also states that it does not store full payment-card numbers. Its FSA/HSA listing identifies a payment route, not proof that every purchase qualifies for reimbursement or that an insurance plan covers treatment. The supplied materials do not document accepted insurers, prior-authorization assistance or guaranteed benefits. Applicable taxes are authorized in the terms, so the advertised price need not be the complete checkout total.
The brand-name cards explicitly warn that availability and coverage may vary. That qualification does not explain whether a listed price is contingent on a particular insurance arrangement, nor does it promise reimbursement. Readers considering those options should request a patient-specific explanation of the charge rather than infer coverage from the medicine’s name. Our guide to insurance and self-pay questions distinguishes payment for the program from benefits for the prescription.
For questions, Tryozi publishes support@tryozi.com and (336) 365-0623. These are useful routes for requesting the selected plan’s first charge, renewal amount, laboratory inclusions and cancellation date in one written explanation. The evidence supplied here is in English and does not establish Spanish-language clinical service or documentation. That is an availability question to ask directly, not evidence that such support is absent.
A lower price does not settle the evidence question
Tryozi acknowledges that its compounded medications are not FDA approved and that compounded versions have not been studied separately. FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, and it is not a provider-specific verdict. The choice requires more than comparing monthly prices.
The supplied evidence does not establish outcomes for Tryozi’s patients or its particular compounded preparations. Results from trials of studied products should not be treated as results purchased through this platform. FDA also reports measurement and administration errors involving compounded medication, some associated with hospitalization; those reports do not establish a Tryozi event rate. Instructions should be clarified with the prescriber or pharmacist rather than reconstructed from a review. Neither the low advertised price nor the pharmacy description resolves those questions.
There are useful administrative disclosures alongside the unresolved commercial terms. Tryozi says advertising and analytics technologies stay off intake, quiz, account and checkout pages. Its privacy notice describes access to medical records, correction requests and confidential communications. The terms also say promotional SMS consent is separate and not required to purchase. These are documented commitments, not independently tested practices. For the purchase decision, they complement—but do not replace—a clear account of who provides care and what the recurring payment includes.
Questions & answers
Is Tryozi’s $79 semaglutide price only for the first month?
The supplied card calls the $79 compounded semaglutide injection offer a lifetime deal billed monthly, not a first-month promotion. It does not explain conditions after cancellation, interruption or re-enrollment. Ask for those conditions and the renewal amount in writing before treating the offer as an unconditional permanent price.
Can I complete Tryozi’s evaluation without being charged?
The homepage advertises free, no-obligation clinician review, but the subscription policy says the first month is charged when intake is completed. The estimate quiz and charge-triggering intake are not clearly reconciled. Ask which exact submission authorizes payment and whether clinical approval happens before or after collection.
Does Tryozi require several months of payment upfront?
Its FAQ requires full upfront collection for multi-week plans, followed by shipments every four weeks. However, the supplied price cards say billed monthly, and the evidence does not identify which plans use prepayment or their totals. Do not assume either universal prepayment or universal month-to-month collection; confirm the selected checkout.
How early must I cancel Tryozi to avoid another charge?
The policy requires receipt of the request at least 72 hours before the billing date. Otherwise, the next cycle is charged and cancellation takes effect on the subsequent billing date. Contact customer service or use the account procedure, if available. Cancellation alone does not entitle you to a refund.
Are Quest or Labcorp tests included in every Tryozi price?
The homepage says standard base labs through Quest or Labcorp are covered with every plan. The policy separately says covered services, labs and medications may vary. The panel, frequency and possible additional testing charges are not specified. Request the laboratory coverage for your selected plan rather than relying solely on the general inclusion list.
Will Tryozi refund me if a clinician says I am ineligible?
The policy offers several formulations: a full refund for medical disqualification, remaining charges after disqualification, and a possible refund. It also limits approved refunds to the most recent cycle. These do not establish a single clear outcome. Ask which provision applies to initial rejection versus later ineligibility and what amount would be returned.
Our assessment
Tryozi provides concrete advertised prices, named service partners and a potentially broad bundle of consultations, labs, medication and shipping. Those disclosures make it possible to investigate the cost meaningfully. The weakness is not an absence of pricing; it is the incomplete reconciliation of that pricing with first-charge timing, multi-week collection, variable inclusions and conflicting refund language. A practical next step is to request a written, plan-specific explanation covering today’s total, the next billing date, covered services, lifetime-price conditions and the applicable medical-disqualification refund. If those answers align with checkout, the offer becomes easier to evaluate. Without them, the headline monthly amount is an incomplete basis for a recurring-care budget.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.